Vaccines Market Size to Reach USD 73.78 Billion in 2028; Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market, Says Reports and Data
02 juin 2021 13h43 HE
|
Reports and Data
New York, June 02, 2021 (GLOBE NEWSWIRE) -- Market Size – USD 42 Billion in 2020 Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global...
Vystar Partners with “Nothing in the Air” for RxAir Marketing, Advertising & Distribution
02 juin 2021 08h30 HE
|
Vystar Corp.
NITA president one of nation’s top 100 TV healthcare content producersLaunching ROKU Campaign June 3 Worcester, MA and PALM DESERT, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s...
Global Antiviral Therapies Market Expected to Surpass to $66,016.5 Million and Exhibit a CAGR of 3.1% from 2020 to 2027 - Exclusive Report [Pages - 208] by Research Dive
12 avr. 2021 09h15 HE
|
Research Dive
New York, USA , April 12, 2021 (GLOBE NEWSWIRE) -- Research Dive in its latest published report estimates that the global antiviral therapies market will generate $66,016.5 million and exhibit...
Antiviral Drugs Market Size & Share | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
12 avr. 2021 06h00 HE
|
Graphical Research
Pune, India, April 12, 2021 (GLOBE NEWSWIRE) -- The global antiviral drugs market size is anticipated to witness accelerated growth during the forecast period due to the growing focus toward...
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
25 févr. 2021 16h01 HE
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended...
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
17 févr. 2021 07h04 HE
|
Vir Biotechnology, Inc.
– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza – – Functional genomics...
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
16 nov. 2020 11h20 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
09 nov. 2020 05h30 HE
|
7 Hills Pharma
HOUSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
It’s Time To Look At UV-C Light Air Purification To Combat COVID-19 More Seriously
02 nov. 2020 08h45 HE
|
Vystar Corp.
Worcester, MA and Palm Springs, CA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- “It’s time to look more seriously at UV-C light air purification to help protect against airborne pathogens such as COVID-19,...
More than 50 PA Organizations, Businesses Encourage Flu Shots
28 oct. 2020 13h58 HE
|
The Hospital and Healthsystem Association of Pennsylvania
Harrisburg, PA, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Today, a group of more than 50 organizations and businesses listed below endorse the following statement: As seasons change, we make preparations...